Tumor cells from NPC patients are regularly and latently infected with EBV. To examine whether the virus serves as target for immune intervention of the cancer, we determined levels of EBV-specific CTLp in peripheral blood from NPC patients, long-term survivors of the cancer and healthy subjects. CT
244: Treatment of Epstein Barr Virus Positive Nasopharyngeal Carcinoma with Adoptively Transferred Cytotoxic T Lymphocytes
✍ Scribed by C.U. Louis; K. Straathof; C. Gerken; D. Cooper-Havlik; V. Torrano; T. Lopez; C.M. Bollard; M.V. Gresik; H. Weiss; A. Gee; M.K. Brenner; C.M. Rooney; H.E. Heslop; S. Gottschalk
- Book ID
- 116280071
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 50 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1083-8791
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND It has been shown that adoptive immunotherapy with Epstein–Barr virus (EBV)‐specific cytotoxic T‐lymphocytes (CTL) is effective for the treatment of EBV‐induced lymphoproliferative disease in stem cell transplantation recipients and organ transplantation recipients. The r
## Abstract Undifferentiated nasopharyngeal carcinoma is very common among Southern Chinese. While most patients have the disease detected and treated early, those who are diagnosed with advanced stages face a poor prognosis. Nasopharyngeal carcinoma is associated with latent Epstein‐Barr virus (EB